A New Oral CLL and SLL Treatment: What Could It Mean for Patients?
The Food and Drug Administration (FDA) recently approved idelalisib (Zydelig), a new oral inhibitor therapy to treat CLL and SLL. Patients now have another option that may spare them the need for chem...
Author: patientpower
Added: 08/03/2014
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
More News: Cancer & Oncology | Food and Drug Administration (FDA)